Global Melatonin Market

Melatonin Market Size, Share, Growth Analysis, By Product Type (Powder/Tablets, Liquid), By Treatment Type (Dietary Supplements, Pharmaceuticals), By Nature, By Region - Industry Forecast 2025-2032

Report ID: SQMIG35I2260 | Region: Global | Published Date: April, 2024
Pages: 260 | Tables: 89 | Figures: 76

Melatonin Market News

  • In August 2022, Pfizer Inc. and Global Blood Therapeutics, Inc. announced today that they have reached an agreement in which Pfizer will acquire GBT for US$ 5.4 billion, a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that provide hope to underserved patient communities, beginning with sickle cell disease (SCD).
  • In December 2020, Natrol LLC, a vitamin, mineral, and supplement producer based in the United States, announced today that New Mountain Capital has purchased Natrol LLC in a partnership that will allow the decades-old firm to continue to grow to its next level of success. Natrol, which is cGMP-certified, manufactures high-quality, unique VMS products, several of which have just been approved by USP, which are all available on the newly eCommerce enabled, as well as through their many retail and online partners in the United States and throughout the world.
  • In August 2019, Natrol LLC announces the release of Natrol Kids Melatonin, an effective, safe, drug-free, and non-habit-forming solution for helping children get enough sleep.
  • In January 2018, Neurim Pharmaceuticals and Biocodex signed a licensing deal today in which Biocodex will have exclusive marketing rights to Neurim's newly developed Rx PedPRM medication in Finland. This is projected to be the first sleep medicine approved for children, treating sleep disturbances in children with autism spectrum disorders (ASD) and neurogenetic diseases.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Melatonin Market size was valued at USD 423.5 million in 2022 and is poised to grow from USD 465.85 million in 2023 to USD 998.59 million by 2031, growing at a CAGR of 10.0% during the forecast period (2024-2031). 

The melatonin market is relatively fragmented, with a high level of competition. Few large players, like Pfizer, GNC, and Neurim Pharma, now control the market in terms of market share. These industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability. 'Pharmavite ', 'Jameison ', 'Rexall Sundown, Inc. ', 'Biotics Research Corporation ', 'Pfizer Inc. ', 'Solgar Inc. ', 'GNC ', 'Xiu Zheng ', 'Church & Dwight Co., Inc. ', 'By-Health ', 'Aurobindo Pharma ', 'Aspen Holdings ', 'B Joshi Agrochem Pharma ', 'Amway Corporation ', 'Neurim Pharmaceuticals ', 'Vitafusion (Church & Dwight brand) ', 'Zenith Nutrition '

Increasing disposable income and the growing number of working professionals due to industrialization and globalization are one of the major factors for increasing instances of insomnia during recent periods. This is caused by an unhealthy lifestyle and food habits which leads to increased sodium intake and is one of the direct or indirect reasons for raising blood pressure which in turn leads to symptoms of insomnia. These will drive the demand for melatonin supplements for reducing stress and insomnia which will drive the global melatonin market during the analysis period.

Melatonin is also employed in the production of bio-based spray polyurethane foam (SPF), which is used in the packing and protection of buildings. These factors would drive the Melatonin Market in the coming years.

In 2021, the North American region dominated the global melatonin market with the largest market and revenue share. The growing problem of insomnia in developed countries due to lifestyle problems and eating habits is the major reason for the growth of demand for melatonin in the united states and Canada and will drive the melatonin market growth in the region. Moreover, according to a report released by the US national library of science in 2021, more than 40% of Canadians have a minimum of one symptom of insomnia and this huge number will propel the melatonin market growth in the North American region during the analysis period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Sleep Disorder Market
Buy Now GET FREE SAMPLE
Sleep Patches Market
Buy Now GET FREE SAMPLE
Sleep Aids Market
Buy Now GET FREE SAMPLE
Melamine Market
Buy Now GET FREE SAMPLE
Dark Spirits Market
Buy Now GET FREE SAMPLE
Morphine Market
Buy Now GET FREE SAMPLE
Tannin Market
Buy Now GET FREE SAMPLE
Cinnamon Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Melatonin Market

Report ID: SQMIG35I2260

$5,300
BUY NOW GET FREE SAMPLE